RNU1-131P

Across TCGA pan-cancer cohorts, RNU1-131P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU1-131P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU1-131P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-131P expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

BRCA, KIRC, and DLBC are the cancer types where RNU1-131P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.608	0.892	<.001	72	view →
KIRC	DFS	Tertile	All	0.281	0.799	.001	57	view →
DLBC	DFS	Tertile	II,III,IV	0.426	0.851	.023	45	view →
BLCA	OS	Tertile	All	0.188	0.618	.012	36	view →
SKCM	DFS	Tertile	II,III,IV	0.058	0.708	<.001	18	view →
OV	OS	Tertile	II,III,IV	0.631	0.706	.048	6	view →
LUSC	DFS	Tertile	II,III,IV	0.772	0.339	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU1-131P–BRCA (DFS)

Open the BRCA breakdown →